FN2 Earnings Intelligence
Merck & Co., Inc. balance sheet (quarterly)
Merck & Co., Inc. (MRK) Balance Sheet (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $14,593 | $8,629 | $8,007 | $18,169 | $5,327 |
| + Debt | $38,131 | $34,844 | $35,402 | $41,374 | $49,117 |
| Enterprise Value | - | - | - | - | - |
| Revenue | $16,657 | $15,529 | $15,806 | $17,276 | $16,286 |
| % Growth | - | - | - | - | - |
| Gross Profit | $12,577 | $12,110 | $12,249 | $13,421 | $12,091 |
| % Margin | 75.5% | 78.0% | 77.5% | 77.7% | 74.2% |
| EBITDA | - | - | - | - | - |
| % Margin | - | - | - | - | - |
| Net Income | $3,157 | $5,079 | $4,427 | $5,785 | -$4,240 |
| % Margin | 19.0% | 32.7% | 28.0% | 33.5% | -26.0% |
| Diluted EPS | $1.24 | $2.01 | $1.76 | $2.32 | -$1.72 |
| % Growth | - | - | - | - | - |
| Operating Cash Flow | - | $2,500 | - | - | $3,918 |
| CapEx | - | $1,328 | - | - | $991 |
| Free Cash Flow | - | $1,172 | - | - | $2,927 |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue | $16,657 | $15,529 | $15,806 | $17,276 | $16,286 |
| Gross Profit | $12,577 | $12,110 | $12,249 | $13,421 | $12,091 |
| EBITDA | - | - | - | - | - |
| Net Income | $3,157 | $5,079 | $4,427 | $5,785 | -$4,240 |
| Diluted EPS | $1.24 | $2.01 | $1.76 | $2.32 | -$1.72 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $14,593 | $8,629 | $8,007 | $18,169 | $5,327 |
| Short-term Debt | $3,149 | $1,360 | $1,434 | $1,405 | $2,444 |
| Long-term Debt | $34,982 | $33,484 | $33,968 | $39,969 | $46,673 |
| Total Debt | $38,131 | $34,844 | $35,402 | $41,374 | $49,117 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $2,500 | - | - | $3,918 |
| Capital Expenditure | - | $1,328 | - | - | $991 |
| Free Cash Flow | - | $1,172 | - | - | $2,927 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 75.5% | 78.0% | 77.5% | 77.7% | 74.2% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 19.0% | 32.7% | 28.0% | 33.5% | -26.0% |
| FCF Margin | - | 7.5% | - | - | 18.0% |
| Diluted EPS Growth | - | - | - | - | - |